Related references
Note: Only part of the references are listed.Sex differences in progression of diabetic nephropathy in OVE26 type 1 diabetic mice
Wanning Wang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2020)
Protection against diabetic cardiomyopathy is achieved using a combination of sulforaphane and zinc in type 1 diabetic OVE26 mice
Jiqun Wang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
TGF-β Signaling in Cellular Senescence and Aging-Related Pathology
Kana Tominaga et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Age- and Tissue-Specific Expression of Senescence Biomarkers in Mice
Adam D. Hudgins et al.
FRONTIERS IN GENETICS (2018)
Vascular Senescence in Cardiovascular and Metabolic Diseases
Goro Katsuumi et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2018)
Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease
Guanghong Jia et al.
DIABETOLOGIA (2018)
The impact of aging on cardiac extracellular matrix
Cesar A. Meschiari et al.
GEROSCIENCE (2017)
Cardiovascular disease progression in female Zucker Diabetic Fatty rats occurs via unique mechanisms compared to males
Kelly Lum-Naihe et al.
SCIENTIFIC REPORTS (2017)
Cardiac fibrosis in the ageing heart: Contributors and mechanisms
Lu Lu et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2017)
Inhibition of HDAC3 prevents diabetic cardiomyopathy in OVE26 mice via epigenetic regulation of DUSP5-ERK1/2 pathway
Zheng Xu et al.
CLINICAL SCIENCE (2017)
Updating Experimental Models of Diabetic Cardiomyopathy
J. Fuentes-Antras et al.
JOURNAL OF DIABETES RESEARCH (2015)
Type 1 Diabetes Mellitus and Cardiovascular Disease A Scientific Statement From the American Heart Association and American Diabetes Association
Sarah D. de Ferranti et al.
CIRCULATION (2014)
Molecular mechanisms of diabetic cardiomyopathy
Heiko Bugger et al.
DIABETOLOGIA (2014)
Metallothionein as a compensatory component prevents intermittent hypoxia-induced cardiomyopathy in mice
Xia Yin et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2014)
The Role of Oxidative Stress and Inflammation in Cardiovascular Aging
Junzhen Wu et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Cardiac Aging and Insulin Resistance: Could Insulin/Insulin-Like Growth Factor (IGF) Signaling be used as a Therapeutic Target?
Sihem Boudina
CURRENT PHARMACEUTICAL DESIGN (2013)
Biological markers of oxidative stress: Applications to cardiovascular research and practice
Edwin Ho et al.
REDOX BIOLOGY (2013)
Sugar, Sex, and TGF-β in Diabetic Nephropathy
Maggie K. Diamond-Stanic et al.
SEMINARS IN NEPHROLOGY (2012)
The Senescence-Associated Secretory Phenotype: The Dark Side of Tumor Suppression
Jean -Philippe Coppe et al.
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2010)
An Update of the Oxidation-Inflammation Theory of Aging: The Involvement of the Immune System in Oxi-Inflamm-Aging
Monica De la Fuente et al.
CURRENT PHARMACEUTICAL DESIGN (2009)
Senescence-messaging secretome: SMS-ing cellular stress
Thomas Kuilman et al.
NATURE REVIEWS CANCER (2009)
Diabetic cardiomyopathy: Insights into pathogenesis, diagnostic challenges, and therapeutic options
Ashish Aneja et al.
AMERICAN JOURNAL OF MEDICINE (2008)
PARP mediates structural alterations in diabetic cardiomyopathy
Jane Chiu et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2008)
Podocyte-Specific Overexpression of the Antioxidant Metallothionein Reduces Diabetic Nephropathy
Shirong Zheng et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor
Jean-Philippe Coppe et al.
PLOS BIOLOGY (2008)
Cellular senescence: when bad things happen to good cells
Judith Campisi et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Attenuation by metallothionein of early cardiac cell death via suppression of mitochondrial oxidative stress results in a prevention of diabetic cardiomyopathy
Lu Cai et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Metallothionein prevents diabetes-induced deficits in cardiomyocytes by inhibiting reactive oxygen species production
G Ye et al.
DIABETES (2003)
Why is soluble intercellular adhesion molecule-1 related to cardiovascular mortality?
A Becker et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2002)
Increased levels of soluble vascular cell adhesion molecule 1 are associated with risk of cardiovascular mortality in type 2 diabetes - The Hoorn study
A Jager et al.
DIABETES (2000)
Share Paper
